Caricamento...
Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report
Metastatic melanoma is an aggressive malignancy. Survival can be increased with the combination of BRAF and MEK inhibition. BRAF inhibitor-induced cutaneous toxicities can be attenuated with MEK inhibition. Here, we describe the first reported case of a patient with metastatic melanoma who developed...
Salvato in:
| Pubblicato in: | SAGE Open Med Case Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6537058/ https://ncbi.nlm.nih.gov/pubmed/31205706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X19847358 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|